The notorious former pharmaceutical CEO, Martin Shkreli, achieved the dubious distinction of being named “the most hated man in America” by several news outlets after raising AIDS and cancer drug prices by 5000 percent. While the so-called “Pharma Bro” has since resigned his position after being charged for participating in a Ponzi scheme, the FDA is trying to ensure, with a small regulatory tweak, that Shkreli-style price-gouging doesn’t happen again.
Conception. Pregnancy. Abortion. Abortifacient.
Those words today are in a rhetorical swamp where contesting religious, medical, and political views muddy understanding. And soon the U.S. Supreme Court will wade in.
On March 25, it will hear challenges to the Affordable Care Act’s provision that employers must provide insurance coverage with no co-pays for contraception.